A payment rate for the new code will be established for Medicare patients through the 2019 Clinical Lab Fee Schedule Annual Public Meeting process.
Study Published in Journal of Clinical Investigation Insight Demonstrates Ability to Predict Early Rejection in Kidney Transplant with FractalDx Portfolio Technology
Today RenalytixAI announced that positive study results have been published in the Journal of Clinical Investigation (JCI) Insight1. These results show FractalDx portfolio technology can accurately predict early acute kidney rejection in transplant patients. Early detection of...
As previously announced, RenalytixAI formed the FractalDx investigator group as part of its commercial program for advanced diagnostic tests expected to make significant improvements in the identification and monitoring for kidney transplant rejection, and to aid in accurate dosing of immune-suppression therapy.